Rachel Schiller
About Rachel Schiller
Rachel Schiller is a Mass Spectrometry Scientist at Adaptimmune in Oxford, United Kingdom, where she has worked since 2019. She has a diverse background in biochemistry and immunology, with previous roles at The Hebrew University of Jerusalem, Eli Lilly and Company, and the University of Oxford.
Work at Adaptimmune
Rachel Schiller has been employed at Adaptimmune since 2019 as a Mass Spectrometry Scientist. In this role, she focuses on optimizing LC-MS settings for proteomics and is involved in mass spectrometry techniques, particularly immunoprecipitation on human tissues. She utilizes sensitive Orbitrap LC-MS/MS mass spectrometers to acquire data, contributing to the generation of a large proteomics database. Additionally, she administers high-throughput MACS Flow Cytometers in the analytical lab and has authored protocols related to mass spectrometry procedures.
Education and Expertise
Rachel Schiller holds a Master’s degree in Structural and Molecular Biochemistry from The Hebrew University, where she studied from 2007 to 2009. She completed her D.Phil. in Biomedical Science at the University of Oxford, focusing on the biochemical characterization of epigenetic enzymes, from 2011 to 2016. In 2018, she furthered her education with a short course in Immunology at Imperial College London. She also completed training in Good Laboratory Practice and High Throughput Flow Cytometry, enhancing her expertise in analytical techniques.
Background
Rachel Schiller began her academic journey at The Hebrew University, where she earned a B.Sc. in Integrated Programme in Biology and Chemistry from 2005 to 2007. She participated in a research program for outstanding undergraduate students at the same institution from 2006 to 2007. Following her undergraduate studies, she engaged in M.Sc. research at The Hebrew University from 2007 to 2009. She also worked as a Research Assistant at the university from 2010 to 2011 before pursuing her D.Phil. at the University of Oxford.
Previous Experience
Before her current position at Adaptimmune, Rachel Schiller gained diverse experience in the field of mass spectrometry and research. She completed a two-month internship at Eli Lilly and Company in 2013 and served as a Postdoctoral Researcher at the University of Oxford for six months in 2017. Her background includes significant research roles at The Hebrew University, where she contributed to various projects and research initiatives.